Objective: To determine the prevalence, causes, provider recognition, and treatment of spasticity
in the long-term care setting. When spasticity is present, to determine what activities
of daily living (ADLs) are most affected, and resident preferences among the available
treatments. Design: Prospective population survey. Setting: A 240-bed long term care facility in Tennessee. Participants: 215 nursing home residents (86 men, 129 women, age range, 13–108y). Interventions: Not applicable. Main Outcome Measures: The presence of spasticity was determined by physical examination. Provider recognition,
etiology, and treatment were determined by medical record review. ADLs impact was
determined by minimum data set (MDS) extraction and caregiver interview. Treatment
preferences were determined by resident interview when the resident had an MDS cognitive
recall score of 2 or higher. Results: 45 residents (21%) had spasticity. Etiologies were stroke (74%), multiple sclerosis
(7%), traumatic brain injury (4%), cerebral palsy (2%), other neurologic disease (4%),
and unknown (9%). 5 (11%) had a previous diagnosis of spasticity in the medical record.
6 (13%) were currently being treated with oral baclofen (4), neurotoxin injections
(1) or physical therapy (1). 30% of residents with spasticity needed complete assistance
(MDS score of 4) with bathing, transferring, and dressing, compared with 5% of residents
without spasticity but with neurologic disease. Spasticity was identified by the primary
direct caregiver as interfering with at least 1 ADLs in 32 participants (71%). Potential
treatment goals included diaper change, hygiene, dressing, splint application, and
transfer to wheelchair. 17 residents (62% of those with spasticity) completed the
treatment preferences interview. Neurotoxin injections and oral medications were the
most popular treatment options (77% were interested) and intrathecal baclofen was
the least popular treatment option (42% were interested). 82% of residents were willing
to consider at least 1 available treatment. Conclusions: The prevalence of spasticity is high in the long-term care setting, and when present
is usually undocumented and untreated. The presence of spasticity makes delivery of
ADLs care more difficult and time consuming.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Archives of Physical Medicine and RehabilitationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Footnotes
Disclosure: J. Bryant, none; P.D. Charles, Medtronic, Inc, research grants; consulting fees or other remuneration, speakers bureau; Allergan, Inc, research grants, consulting fees or other remuneration, speakers bureau; C.E. Gill, none; J.F. Schnelle, none; S.F. Simmons, none.
Identification
Copyright
© 2008 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.